Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.3 USD | -0.38% | +2.43% | +20.93% |
Jun. 11 | Merck looks for next-generation opportunities in cardiometabolic drugs | RE |
Jun. 11 | Merck & Co., Inc. to Seek Acquisitions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.93% | 334B | |
+48.53% | 780B | |
+41.41% | 627B | |
+8.21% | 296B | |
+17.85% | 244B | |
-0.78% | 217B | |
+11.54% | 214B | |
+4.40% | 161B | |
-2.64% | 159B | |
-0.41% | 121B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck's Late-Stage Study for Cancer Drug Keytruda Plus Chemotherapy Fails to Meet Primary Endpoint